4//SEC Filing
Gilde Healthcare IV Management B.V. 4
Accession 0000899243-20-032404
CIK 0001531048other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 8:04 PM ET
Size
29.2 KB
Accession
0000899243-20-032404
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2020-11-30$65.81/sh−14,770$972,014→ 7,848,269 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$68.81/sh−39,955$2,749,304→ 7,663,823 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$67.93/sh−73,435$4,988,440→ 7,501,953 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$69.07/sh−2,818$194,639→ 7,499,135 total(indirect: See footnote) - Sale
Common Stock
2020-11-27$66.99/sh−13,956$934,912→ 7,927,723 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$66.94/sh−65,795$4,404,317→ 7,782,474 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$67.06/sh−88,435$5,930,451→ 7,575,388 total(indirect: See footnote) - Sale
Common Stock
2020-11-27$68.28/sh−11,200$764,736→ 7,916,523 total(indirect: See footnote) - Sale
Common Stock
2020-11-27$68.94/sh−53,484$3,687,187→ 7,863,039 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$67.74/sh−78,696$5,330,867→ 7,703,778 total(indirect: See footnote)
Gilde Healthcare IV Management B.V.
10% Owner
Transactions
- Sale
Common Stock
2020-11-27$68.94/sh−53,484$3,687,187→ 7,863,039 total(indirect: See footnote) - Sale
Common Stock
2020-11-27$68.28/sh−11,200$764,736→ 7,916,523 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$66.94/sh−65,795$4,404,317→ 7,782,474 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$67.06/sh−88,435$5,930,451→ 7,575,388 total(indirect: See footnote) - Sale
Common Stock
2020-11-27$66.99/sh−13,956$934,912→ 7,927,723 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$69.07/sh−2,818$194,639→ 7,499,135 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$67.93/sh−73,435$4,988,440→ 7,501,953 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$67.74/sh−78,696$5,330,867→ 7,703,778 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$68.81/sh−39,955$2,749,304→ 7,663,823 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$65.81/sh−14,770$972,014→ 7,848,269 total(indirect: See footnote)
Gilde Healthcare Holding B.V.
10% Owner
Transactions
- Sale
Common Stock
2020-11-27$68.94/sh−53,484$3,687,187→ 7,863,039 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$67.93/sh−73,435$4,988,440→ 7,501,953 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$65.81/sh−14,770$972,014→ 7,848,269 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$66.94/sh−65,795$4,404,317→ 7,782,474 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$67.74/sh−78,696$5,330,867→ 7,703,778 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$67.06/sh−88,435$5,930,451→ 7,575,388 total(indirect: See footnote) - Sale
Common Stock
2020-12-01$69.07/sh−2,818$194,639→ 7,499,135 total(indirect: See footnote) - Sale
Common Stock
2020-11-27$66.99/sh−13,956$934,912→ 7,927,723 total(indirect: See footnote) - Sale
Common Stock
2020-11-27$68.28/sh−11,200$764,736→ 7,916,523 total(indirect: See footnote) - Sale
Common Stock
2020-11-30$68.81/sh−39,955$2,749,304→ 7,663,823 total(indirect: See footnote)
Footnotes (11)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.555 to $67.41, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.49 to $68.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.50 to $69.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.565 to $68.55, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.56 to $69.50, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.28 to $66.27, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.29 to $67.275, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.30 to $68.28, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.30 to $69.15, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.49 to $67.4875, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Inari Medical, Inc.
CIK 0001531048
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001757508
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 8:04 PM ET
- Size
- 29.2 KB